Navigation Links
Chuback Medical Group Raises Awareness for the Serious Vein Condition Deep Vein Thrombosis
Date:3/19/2013

Paramus, NJ (PRWEB) March 19, 2013

Paramus, NJ. Chuback Medical Group, a leading vein treatment center in Bergen County, New Jersey, is doing its part to reach out to the public and raise awareness for a serious vein condition.

March is Deep Vein Thrombosis (DVT) month, and the Chuback Medical Group has joined in the effort to decrease the number of serious illnesses and deaths as a result of DVT. DVT is a condition in which blood clots form in the deep leg veins. Clots can break free and travel to the lungs, potentially causing pulmonary embolism. This can be fatal if not detected and treated early.

Under the direction of Dr. John Chuback, a top vein disease specialist in Bergen County, NJ, the vein clinic is using Facebook and Twitter to spread the word about this vein disorder. Chuback Medical Group has released an informative video about deep vein thrombosis to help empower the public to protect their health. Everyone should learn the symptoms and risk factors for this vein problem and seek venous disease treatment if needed.

For more information, go to:

Varicose Vein Treatment Options

Chuback Medical Group offers patients a variety of varicose vein and spider vein treatment options. Each patient is carefully evaluated to identify the best vein treatment plan to meet their unique needs. Whenever possible, the vein center will recommend conservative treatment as a first step. This may include using compression stockings or making healthy lifestyle changes. If additional treatment for vein disease is needed, Chuback Medical Group provides leading edge therapies including sclerotherapy, phlebectomy, and endovenous laser ablation.

Patients can also find useful educational information about vein disease on the clinic’s website. That includes easy-to-understand explanations of common vein conditions, symptoms, and treatments. At Chuback Medical Group, the focus is on providing the best vein treatment care in Bergen County, NJ.

About Chuback Medical Group

Chuback Medical Group is a leading care provider specializing in vein disorders, aesthetic services, and medical weight loss. Located in Bergen County, New Jersey, the clinic strives to provide patients with customized care for the face and body, using safe and effective noninvasive and minimally invasive therapies. The highly trained medical staff has extensive knowledge and expertise treating vein disorders such as varicose veins and spider veins, as well as in cosmetic medicine and healthy weight loss. Medical Director and chief vein specialist Dr. John Chuback, MD, is a leading expert in the treatment of varicose veins using minimally invasive laser technology, and a decorated provider of superior patient care for the full range of vein conditions.

Chuback Medical Group
Tel. 201-693-4847

Read the full story at http://www.prweb.com/releases/2013/3/prweb10519027.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Presidents Bioethics Commission releases report on pediatric medical countermeasure research
2. Rejuv Medical Sponsoring Minnesota’s Annual iRock Run
3. M.D. International Studies Innovative Pre-Medical Courses Arrives in USA
4. Cloud Medical Doctor Software Corporation Finalizes Acquisition of Doctors Network of America and Expands its Medical Billing Services West
5. Innovative Medical Marijuana Growing Product added to PotLocator.com Lineup
6. Health2Go Announces Medical Research Showing DHEA Improves Health and Benefits Skin
7. Medical Marketing Firm MCPR Introduces Sports Medicine Expert for Media Interviews
8. UH Case Medical Center awarded highest certification as Comprehensive Stroke Center
9. Peter Piot awarded Hideyo Noguchi Africa Prize for Medical Research
10. Corporate Whistle Blower Center Urges Physicians To Call them--If They Have Proof A Medical Device Company Was Knowingly Selling Defective Products
11. Launch of Chinese-German Center for Bio-Inspired Materials at Mainz University Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... The American Board of ... its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon his ... July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon assuming ...
(Date:10/13/2017)... ... October 13, 2017 , ... Apple Rehab Shelton Lakes , which specializes ... of the facility as part of a disaster drill on October 3rd. , Apple ... Shelton City Emergency Manager, as well as the Connecticut Long Term Care Mutual ...
(Date:10/13/2017)... Abilene, Texas (PRWEB) , ... October 13, 2017 , ... ... publication this week that explains one of the most popular and least understood books ... seems like cryptic and puzzling descriptions that have baffled scholars for centuries. Many have ...
(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare ... program management, will showcase a range of technology and learning solutions at the ... Convention and Expo to be held October 14–18, 2017 at the Mandalay Bay ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical Informatics (ACMI) will ... during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. AMIA’s Annual ... F. Collen, a pioneer in the field of medical informatics, this prestigious award is ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
(Date:9/28/2017)... Cohen Veterans Bioscience and Early Signal Foundation ... and home sensors for real-time monitoring of patients with ... nonprofit organization focused on disruptive health solutions for rare ... system to record and integrate behavioral, cognitive, physiological and ... ...
(Date:9/23/2017)... 22, 2017 Janssen Biotech, Inc. (Janssen) announced ... from the U.S. Food and Drug Administration (FDA) for ... for the treatment of moderately to severely active rheumatoid ... data are needed to further evaluate the safety of ... RA. "We ...
Breaking Medicine Technology: